Europe Solidaire Sans Frontières
The new bivalent boosters against COVID-19 have failed to halt omicron infections. However, new technologies are being developed that pave a way forward.
By almost any measure, the vaccination campaign against SARS-CoV-2, the virus that causes COVID-19, has been a global success.
As of (...)
Nearly all the wastewater samples from aircraft arriving in the UK showed evidence of COVID-infected passengers on board.
Small traces of many pathogens, such as viruses we may be infected with, are excreted when we go to the toilet. Ultimately, these agents find their way to municipal (...)
After a year of omicron variants, will we ever see a new variant of concern?
The omicron variant of SARS-CoV-2, the virus that causes COVID-19, has now been around for more than a year. Before omicron became dominant, there had been a quick succession of named variants of concern – from alpha, (...)
While there are still far more questions than answers about long COVID-19, researchers are beginning to get a clearer picture of the health and economic consequences of the condition.
The Research Brief is a short take about interesting academic work.
The big idea
Even mild COVID-19 cases (...)
Masks are an easy and low-cost way to reduce the amount of virus entering the air and spreading to others.
The cold and flu season of 2022 has begun with a vengeance. Viruses that have been unusually scarce over the past three years are reappearing at remarkably high levels, sparking a (...)
There have been enough COVID infections in the UK since March 2020 for every person to have been infected between 1.3 and two times, according to mathematical modelling.
Of course, some people will have had COVID more than twice, and some won’t have had it at all. But COVID is not a “one and (...)
Almost three years into the pandemic, myths and misinformation remain widespread. Here we, a virologist and a public health researcher, debunk some common misconceptions about COVID.
--------------------
Myth 1: The virus is becoming milder
There’s a prevailing myth in the omicron era that (...)
Nov 10 (Reuters) - The risk of death, hospitalization and serious health issues from COVID-19 jumps significantly with reinfection compared with a first bout with the virus, regardless of vaccination status, a study published on Thursday suggests.
“Reinfection with COVID-19 increases the risk (...)
Two new omicron subvariants, BQ.1 and BQ.1.1 could lead to another COVID surge. Here’s what we know so far.
Two new omicron subvariants, BQ.1 and BQ.1.1, are quickly gaining traction in the US, collectively accounting for 27% of infections as of October 29. Both are descendants of BA.5, the (...)
How will long Covid play out over the coming years? Eight experts weigh in The story of long Covid is just beginning, and no one knows how it will play out. Experts from around the world share their insights, questions and fears
The story of long Covid is just beginning, and no one – not even (...)
The impact of long Covid needs urgent action – and there are five key elements to drive the effort forward, writes the WHO director general
Crushing fatigue. Brain fog making straightforward tasks almost impossible. Shortness of breath walking up the stairs.
Just some of the many symptoms (...)
Since health officials confirmed the first COVID-19 cases, misinformation has spread just as quickly as the virus. Social media may have made the amount, variety and speed of misinformation seem unprecedented, but COVID-19 isn’t the first pandemic where false and harmful information has set back (...)
In places around the world that lack restrictions to combat the problem, tobacco companies are using marketing strategies aimed at children, like displaying tobacco products at kids’ eye level.
The big idea
The world’s largest multinational tobacco companies are advertising cigarettes to kids (...)
While the majority of monkeypox cases thus far have been recorded among men who have sex with men, everyone is still at risk of contracting the disease.
Monkeypox is caused by a virus that, despite periodic outbreaks, is not thought to spread easily from person to person and historically has (...)
Viruses that cause respiratory diseases like the flu and COVID-19 can lead to mild to severe symptoms within the first few weeks of infection. These symptoms typically resolve within a few more weeks, sometimes with the help of treatment if severe. However, some people go on to experience (...)
Among the mosquito-borne diseases, dengue remains to be a major public health concern.
One smooth operator, SHE has the eyes to see and track you with, an extra nose to better smell you with, the wings to fly, and six strong toned legs. Legs that allow her to stand on water, execute that (...)
The BA.5 subvariant is better able to evade the body’s immune system than previous subvariants. Face masks are still an effective way to help stop the spread of the BA.5 subvariant.
The omicron subvariant known as BA.5 was first detected in South Africa in February 2022 and spread rapidly (...)
The World Health Organisation (WHO) has declared the current monkeypox epidemic a global health emergency.
The committee of independent advisers who met on Thursday July 21 2022, were split on their decision on whether to call the growing monkeypox outbreak a public health emergency of (...)
The monkeypox virus, which is commonly found in West and Central Africa, is now causing many infections in the U.S., Europe and Latin America.
Monkeypox is the latest global public health threat to make headlines. Most people who contract the monkeypox virus experience flu-like symptoms and a (...)
Scientists are investigating whether reservoirs of virus ‘hiding’ in the body are contributing to long Covid
Since the early days of the pandemic it has been clear some people shed genetic material from the virus in their stools for months after catching Covid-19. The findings were initially (...)
Twitter
Facebook